Information Provided By:
Fly News Breaks for January 20, 2017
MCK
Jan 20, 2017 | 08:08 EDT
Leerink analyst David Larsen lowered his price target for McKesson to $155 from $160 as he believes volume and pricing trends remain challenges, the FDA will likely continue with a steady stream of generic approvals which will put pressure on pricing, Trump may be more aggressive about price controls than expected, and as the company's competitive positioning in the market has weakened due to purchasing scale. The analyst reiterates a Market Perform rating on the shares.
News For MCK From the Last 2 Days
There are no results for your query MCK